Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma
Journal Article
Overview
publication date
has subject area
-
Cell Physiological Phenomena - Cell Movement
-
Cell Physiological Phenomena - Cell Proliferation
-
Diagnostic Techniques and Procedures - In Situ Hybridization, Fluorescence
-
Diagnostic Techniques and Procedures - In Situ Hybridization, Fluorescence
-
Environment and Public Health - Cohort Studies
-
Gefitinib
-
Gene Expression Regulation - Gene Amplification
-
Genetic Techniques - In Situ Hybridization, Fluorescence
-
Genetic Techniques - In Situ Hybridization, Fluorescence
-
Growth - Cell Proliferation
-
Health Care Evaluation Mechanisms - Cohort Studies
-
Humans
-
Investigative Techniques - Cohort Studies
-
Investigative Techniques - In Situ Hybridization, Fluorescence
-
Investigative Techniques - In Situ Hybridization, Fluorescence
-
Mutagenesis - Gene Amplification
-
Mutation - Gene Amplification
-
Neoplasms, Germ Cell and Embryonal - Glioblastoma
-
Neoplasms, Glandular and Epithelial - Glioblastoma
-
Neoplasms, Nerve Tissue - Glioblastoma
-
Organ Culture Techniques
-
Physiological Phenomena - Cell Movement
-
Protein Kinase Inhibitors
-
Protein-Tyrosine Kinases - ErbB Receptors
-
Quinazolines
-
Receptors, Cell Surface - ErbB Receptors
-
Receptors, Growth Factor - ErbB Receptors
-
Tumor Cells, Cultured
has restriction
Date in CU Experts
-
January 30, 2018 10:48 AM
Full Author List
-
Parker JJ; Dionne KR; Massarwa R; Klaassen M; Foreman NK; Niswander L; Canoll P; Kleinschmidt-DeMasters BK; Waziri A
author count
citation count
published in
Other Profiles
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue